Today is Sunday, Oct. 13, 2019

Department of

Cancer Biology

  • Jensen Symposium
  • State-of-the-Art Labs and Facilities
  • Competitive National Graduate Program

Cincinnati Cancer Research Retreat 2019

Cancer Metabolism

Cincinnati Cancer Research Retreat 2019

Click here for Registration and Abstract Submission details

About Cancer Biology

Cancer Biology Faculty and Students

The Cancer Biology Department is the home of a dynamic, collaborative and highly interactive faculty with cutting-edge research programs that span a wide range of cancer-related topics.

Every new discovery and success in our laboratories—big and small—is putting our dreams of eradicating (or controlling) cancer closer than ever to reality. We hope you will join us in our fight against cancer through basic and translational research at this most opportune and exciting time.

We invite you to learn more about:

Recent Publications

Graduate Students

The following publications have been recently published by Cancer Biology faculty:

  • Goyal, Lipika; Shi, Lei; Liu, Leah Y; Fece de la Cruz, Ferran; Lennerz, Jochen K; Raghavan, Srivatsan; Leschiner, Ignaty; Elagina, Liudmila; Siravegna, Giulia; Ng, Raymond W S; Vu, Phuong; Patra, Krushna C; Saha, Supriya K; Uppot, Raul N; Arellano, Ron; Reyes, Stephanie; Sagara, Takeshi; Otsuki, Sachie; Nadres, Brandon; Shahzade, Heather A; Dey-Guha, Ipsita; Fetter, Isobel J; Baiev, Islam; Van Seventer, Emily E; Murphy, Janet E; Ferrone, Cristina R; Tanabe, Kenneth K; Deshpande, Vikram; Harding, James J; Yaeger, Rona; Kelley, Robin K; Bardelli, Alberto; Iafrate, A John; Hahn, William C; Benes, Cyril H; Ting, David T; Hirai, Hiroshi; Getz, Gad; Juric, Dejan; Zhu, Andrew X; Corcoran, Ryan B; Bardeesy, Nabeel 2019. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaCancer discovery, 9 8, 1064-1079
  • Zachari, Maria; Gudmundsson, Sigurdur R; Li, Ziyue; Manifava, Maria; Shah, Ronak; Smith, Matthew; Stronge, James; Karanasios, Eleftherios; Piunti, Caterina; Kishi-Itakura, Chieko; Vihinen, Helena; Jokitalo, Eija; Guan, Jun-Lin; Buss, Folma; Smith, Andrew M; Walker, Simon A; Eskelinen, Eeva-Liisa; Ktistakis, Nicholas T 2019. Selective Autophagy of Mitochondria on a Ubiquitin-Endoplasmic-Reticulum PlatformDevelopmental cell, 50(5):627-643.e5.
  • Melgar, Katelyn; Walker, Morgan M; Jones, LaQuita M; Bolanos, Lyndsey C; Hueneman, Kathleen; Wunderlich, Mark; Jiang, Jiang-Kang; Wilson, Kelli M; Zhang, Xiaohu; Sutter, Patrick; Wang, Amy; Xu, Xin; Choi, Kwangmin; Tawa, Gregory; Lorimer, Donald; Abendroth, Jan; O'Brien, Eric; Hoyt, Scott B; Berman, Ellin; Famulare, Christopher A; Mulloy, James C; Levine, Ross L; Perentesis, John P; Thomas, Craig J; Starczynowski, Daniel T 2019. Overcoming adaptive therapy resistance in AML by targeting immune response pathways. Science translational medicine, 11 508
  • Kofuji, S.; Hirayama, A.; Eberhardt, A. O.; Kawaguchi, R.; Sugiura, Y.; Sampetrean, O.; Ikeda, Y.; Warren, M.; Sakamoto, N.; Kitahara, S.; Yoshino, H.; Yamashita, D.; Sumita, K.; Wolfe, K.; Lange, L.; Ikeda, S.; Shimada, H.; Minami, N.; Malhotra, A.; Morioka, S.; Ban, Y.; Asano, M.; Flanary, V. L.; Ramkissoon, A.; Chow, L. M L; Kiyokawa, J.; Mashimo, T.; Lucey, G.; Mareninov, S.; Ozawa, T.; Onishi, N.; Okumura, K.; Terakawa, J.; Daikoku, T.; Wise-Draper, T.; Majd, N.; Kofuji, K.; Sasaki, M.; Mori, M.; Kanemura, Y.; Smith, E. P; Anastasiou, D.; Wakimoto, H.; Holland, E. C; Yong, W. H; Horbinski, C.; Nakano, I.; DeBerardinis, R. J.; Bachoo, R. M.; Mischel, P. S; Yasui, W..; Suematsu, M.; Saya, H.; Soga, T.; Grummt, I.; Bierhoff, H.; Sasaki, Atsuo, T. 2019. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nature Cell Biology. 21(8):1003-1014
  • Sliz, Anna; Locker, Kathryn C S; Lampe, Kristin; Godarova, Alzbeta; Plas, David R; Janssen, Edith M; Jones, Helen; Herr, Andrew B; Hoebe, Kasper 2019. Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy. Science Immunology, 4, 38.
  • Brose, Nils; Brunger, Axel; Cafiso, David; Chapman, Edwin R; Diao, Jiajie; Hughson, Frederick M; Jackson, Meyer B; Jahn, Reinhard; Lindau, Manfred; Ma, Cong; Rizo, Josep; Shin, Yeon-Kyun; Söllner, Thomas H; Tamm, Lukas; Yoon, Tae-Young; Zhang, Yongli 2019. Synaptic vesicle fusion: today and beyondNature Structural & Molecular Biology, 26 8, 663-668


Latest News/Events

Congratulations to Xiaoting Zhang, PhD!

Dr. Zhang, Cancer Biology professor, has been awarded his second NIH R01 from the National Cancer Institute.  The five year grant entitled “Small RNAs in Breast Cancer Metastasis” will focus on the regulation and function of a key tissue-specific estrogen receptor coactivator MED1 and its upstream and downstream small RNA pathways in breast cancer.

Congratulations to JJ Diao, PhD!

Dr. Diao, Cancer Biology assistant professor, has been awarded an NIH R21 from the National Institute on Aging.  The two year grant entitled “Single-molecule study of alpha-synuclein” will focus on multiple single-molecule/single-particle biophysical and biochemical assays used to characterize the oligomerization and function of α-synuclein in membrane environments mimicking presynaptic terminals.

Congratulations to Maria Czyzyk-Krzeska, PhD!

Dr. Czyzyk-Krzeska, Cancer Biology professor, has been awarded an NIH R01 from the National Institute of General Medical Sciences.  The four year grant entitled “Mechanisms of selective autophagy” will focus on a novel, selective, human-specific autophagy downstream from the von Hippel Lindau tumor suppressor gene;  a pathway that is regulated by several non-canonical regulators and targets for degradation oncogenic cargo.

Promotion to Professor for Xiaoting Zhang, PhD

On September 1, 2019, Xiaoting Zhang, PhD, in the department of Cancer Biology was promoted to Professor.  Congratulations Dr. Zhang!

Congratulations to Chunying Du, PhD!

Dr. Du, Cancer Biology associate professor, has been awarded an NIH R21 from the National Cancer Institute.  The two year grant entitled “Novel Targeting of Liver Cancer Deficient of DNA Repair” will focus on a DNA damage repair mechanism underlying the development of the most common form of malignancy in the liver - hepatocellular carcinoma (HCC) - by loss of the new HCC suppressor BRUCE.